U.S. Markets closed

Roche’s Immunotherapy Drug Tecentriq Extended Patients’ Lives in Study

Roche Holding said its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, bolstering the Swiss drugmaker’s defense against a wave ...